It has also been recently described an ANXA2-targeting peptide motif CBP12 with highly selectivity and affinity to ANXA2 and proved ability to specifically target colorectal cancer cells, therefore emerging as a candidate for ANXA2-targeted therapeutic strategies (Staquicini et al., 2017). The gene discussed is ANXA2; the disease is colorectal cancer.